As of Oct 02
| +0.84 / +2.35%|
The 5 analysts offering 12-month price forecasts for Amedisys Inc have a median target of 45.00, with a high estimate of 52.00 and a low estimate of 40.00. The median estimate represents a +23.19% increase from the last price of 36.53.
The current consensus among 9 polled investment analysts is to Buy stock in Amedisys Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.